226 related articles for article (PubMed ID: 32621329)
1. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.
Ebadi M; Bhanji RA; Tandon P; Mazurak V; Baracos VE; Montano-Loza AJ
Aliment Pharmacol Ther; 2020 Aug; 52(4):600-618. PubMed ID: 32621329
[TBL] [Abstract][Full Text] [Related]
2. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
Ebadi M; Tandon P; Moctezuma-Velazquez C; Ghosh S; Baracos VE; Mazurak VC; Montano-Loza AJ
J Hepatol; 2018 Sep; 69(3):608-616. PubMed ID: 29709682
[TBL] [Abstract][Full Text] [Related]
3. Adipopenia correlates with higher portal pressure in patients with cirrhosis.
Rodrigues SG; Brabandt B; Stirnimann G; Maurer MH; Berzigotti A
Liver Int; 2019 Sep; 39(9):1672-1681. PubMed ID: 31207018
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
Montano-Loza AJ; Mazurak VC; Ebadi M; Meza-Junco J; Sawyer MB; Baracos VE; Kneteman N
Hepatology; 2018 Mar; 67(3):914-923. PubMed ID: 29023899
[TBL] [Abstract][Full Text] [Related]
6. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of skeletal muscle abnormalities in patients with cirrhosis.
Ebadi M; Montano-Loza AJ
Dig Liver Dis; 2019 Nov; 51(11):1493-1499. PubMed ID: 31221549
[TBL] [Abstract][Full Text] [Related]
8. Visceral Adipose Tissue Index and Hepatocellular Carcinoma Are Independent Predictors of Outcome in Patients with Cirrhosis Having Endoscopic Treatment for Esophageal Varices.
Kimura N; Tsuchiya A; Oda C; Kimura A; Hosaka K; Tominaga K; Hayashi K; Yokoyama J; Terai S
Dig Dis; 2021; 39(1):58-65. PubMed ID: 32450556
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.
Hara N; Iwasa M; Sugimoto R; Mifuji-Moroka R; Yoshikawa K; Terasaka E; Hattori A; Ishidome M; Kobayashi Y; Hasegawa H; Iwata K; Takei Y
Intern Med; 2016; 55(8):863-70. PubMed ID: 27086797
[TBL] [Abstract][Full Text] [Related]
10. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
[TBL] [Abstract][Full Text] [Related]
11. Estimation of adipose pools in hemodialysis patients from anthropometric measures.
Kaysen GA; Kotanko P; Zhu F; Sarkar SR; Heymsfield SB; Kuhlmann MK; Levin NW
J Ren Nutr; 2008 Nov; 18(6):473-8. PubMed ID: 18940649
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis.
Ha NB; Montano-Loza AJ; Carey EJ; Lin S; Shui AM; Huang CY; Dunn MA; Lai JC
Am J Transplant; 2022 Sep; 22(9):2195-2202. PubMed ID: 35486028
[TBL] [Abstract][Full Text] [Related]
13. Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis.
Feng H; Wang X; Zhao T; Mao L; Hui Y; Fan X; Lin L; Zhao W; Jiang K; Wang B; Yu Q; Zhang J; Sun C
Clin Nutr; 2021 Apr; 40(4):1983-1989. PubMed ID: 32977996
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
Ebadi M; Martin L; Ghosh S; Field CJ; Lehner R; Baracos VE; Mazurak VC
Br J Cancer; 2017 Jun; 117(1):148-155. PubMed ID: 28588319
[TBL] [Abstract][Full Text] [Related]
15. Impact of visceral fat accumulation on the prognosis of patients with cirrhosis.
Ishizu Y; Ishigami M; Honda T; Imai N; Ito T; Yamamoto K; Fujishiro M
Clin Nutr ESPEN; 2021 Apr; 42():354-360. PubMed ID: 33745605
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children.
Maffeis C; Manfredi R; Trombetta M; Sordelli S; Storti M; Benuzzi T; Bonadonna RC
J Clin Endocrinol Metab; 2008 Jun; 93(6):2122-8. PubMed ID: 18397988
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease.
Tachi Y; Kozuka A; Hirai T; Kojima Y; Ishizu Y; Honda T; Kuzuya T; Hayashi K; Ishigami M; Goto H
Nutrition; 2018 Oct; 54():83-88. PubMed ID: 29753174
[TBL] [Abstract][Full Text] [Related]
18. Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study.
Benjamin J; Shasthry V; Kaal CR; Anand L; Bhardwaj A; Pandit V; Arora A; Rajesh S; Pamecha V; Jain V; Kumar G; Loria A; Puri P; Joshi YK; Sarin SK
Liver Int; 2017 Nov; 37(11):1668-1674. PubMed ID: 29065258
[TBL] [Abstract][Full Text] [Related]
19. Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
Vrieling A; Kampman E; Knijnenburg NC; Mulders PF; Sedelaar JPM; Baracos VE; Kiemeney LA
Eur Urol Focus; 2018 Apr; 4(3):420-434. PubMed ID: 28753824
[TBL] [Abstract][Full Text] [Related]
20. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
